ADP and Thromboxane Inhibitors Both Reduce Global Contraction of Clot Length, While Thromboxane Inhibition Attenuates Internal Aggregate Contraction

Platelet contractility drives clot contraction to enhance clot density and stability. Clot contraction is typically studied under static conditions, with fewer studies of wall-adherent platelet clots formed under flow. We tested the effect of inhibitors of ADP and/or thromboxane A2 (TXA2) signaling...

Descripción completa

Detalles Bibliográficos
Autores principales: Trigani, Kevin T., DeCortin, Michael E., Diamond, Scott L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9192180/
https://www.ncbi.nlm.nih.gov/pubmed/35707619
http://dx.doi.org/10.1055/a-1832-9293

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9192180/
https://www.ncbi.nlm.nih.gov/pubmed/35707619
http://dx.doi.org/10.1055/a-1832-9293

Ejemplares similares